These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Lee DL; Hodges RS Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499 [TBL] [Abstract][Full Text] [Related]
30. The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity. Jacob B; Rajasekaran G; Kim EY; Park IS; Bang JK; Shin SY Amino Acids; 2016 May; 48(5):1241-51. PubMed ID: 26795535 [TBL] [Abstract][Full Text] [Related]
31. Rational design and synthesis of Oreoch-2 analogues as efficient broad-spectrum antimicrobial peptides. Zhang N; Gu X; Song D; Zhang P; Zhang N; Chen W; Ji S; Qi Y; Ma S Bioorg Chem; 2022 Feb; 119():105583. PubMed ID: 34971943 [TBL] [Abstract][Full Text] [Related]
32. Cecropin A - magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect. Shin SY; Kang JH; Lee MK; Kim SY; Kim Y; Hahm KS Biochem Mol Biol Int; 1998 May; 44(6):1119-26. PubMed ID: 9623765 [TBL] [Abstract][Full Text] [Related]
33. Improving the Therapeutic Index of Smp24, a Venom-Derived Antimicrobial Peptide: Increased Activity against Gram-Negative Bacteria. Rawson KM; Lacey MM; Strong PN; Miller K Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887325 [TBL] [Abstract][Full Text] [Related]
34. Development of Bifunctional, Raman Active Diyne-Girder Stapled α-Helical Peptides. Morgan DC; McDougall L; Knuhtsen A; Jamieson AG Chemistry; 2023 Jul; 29(41):e202300855. PubMed ID: 37130830 [TBL] [Abstract][Full Text] [Related]
35. Chemical modifications to increase the therapeutic potential of antimicrobial peptides. Han Y; Zhang M; Lai R; Zhang Z Peptides; 2021 Dec; 146():170666. PubMed ID: 34600037 [TBL] [Abstract][Full Text] [Related]
36. Tuning the biological properties of amphipathic alpha-helical antimicrobial peptides: rational use of minimal amino acid substitutions. Zelezetsky I; Pag U; Sahl HG; Tossi A Peptides; 2005 Dec; 26(12):2368-76. PubMed ID: 15939509 [TBL] [Abstract][Full Text] [Related]
37. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides. Mai XT; Huang J; Tan J; Huang Y; Chen Y J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179 [TBL] [Abstract][Full Text] [Related]
38. Highly selective performance of rationally designed antimicrobial peptides based on ponericin-W1. Lv S; Wang J; You R; Liu S; Ding Y; Hadianamrei R; Tomeh MA; Pan F; Cai Z; Zhao X Biomater Sci; 2022 Aug; 10(17):4848-4865. PubMed ID: 35861280 [TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity. Zhong C; Liu T; Gou S; He Y; Zhu N; Zhu Y; Wang L; Liu H; Zhang Y; Yao J; Ni J Eur J Med Chem; 2019 Nov; 182():111636. PubMed ID: 31466017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]